Corpus Intelligence IC Memo — ENCOMPASS HEALTH VALLEY OF THE SUN R 2026-04-26 09:34 UTC
IC Memo — ENCOMPASS HEALTH VALLEY OF THE SUN R
Investment Committee Memorandum | AZ | 75 beds | Grade C | EBITDA uplift $1.7M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

ENCOMPASS HEALTH VALLEY OF THE SUN R

CCN 033032 | MARICOPA, AZ | 75 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

ENCOMPASS HEALTH VALLEY OF THE SUN R is a 75-bed suburban community hospital in MARICOPA, AZ with $22.6M in net patient revenue and a 3.7% operating margin. The hospital serves a payer mix of 32.5% Medicare, 1.2% Medicaid, and 66.3% commercial.

Thesis: Turnaround. Our ML models identify $1.7M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 3.7% to 11.1% (+736bps).

Net Revenue HCRIS$22.6M
Current EBITDA COMPUTED$845K
Operating Margin COMPUTED3.7%
Occupancy HCRIS54.4%
Revenue / Bed COMPUTED$301K
Net-to-Gross HCRIS64.4%
Distress Probability ML51.7%

2. Market Context & Competitive Position

124
AZ Hospitals
-0.8%
State Median Margin
54
Comparable Hospitals

AZ has 124 Medicare-certified hospitals with a median operating margin of -0.8%. The target's margin of 3.7% places it above the state median. Among 54 size-comparable peers (38-150 beds), the median margin is 2.2%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (38-150), prioritizing same-state peers. 54 hospitals in the comp set.

HospitalStateBedsRevenueMargin
ENCOMPASS HEALTH VALLEY OF THE (Target)AZ75$22.6M3.7%
HAVASU REGIONAL MEDICAL CENTERAZ144$256.1M16.9%
SUMMIT HEALTHCAREAZ89$254.1M-2.9%
BANNER UNIVERSITY MED CENTER SAZ132$190.9M-16.3%
HONORHEALTH SCOTTSDALE THOMPSOAZ120$187.9M-1.6%
VERDE VALLEY MEDICAL CENTERAZ87$172.5M4.3%
BANNER HEART HOSPITALAZ108$162.2M17.4%
BANNER CASA GRANDE MEDICAL CENAZ141$151.2M-6.3%
NORTHWEST MEDICAL CENTER ORO VAZ96$145.8M10.6%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.7M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$475K+210bp18mo
Cost to Collect4.5%2.5%$452K+200bp12mo
Denial Rate Reduction12.0%6.5%$447K+198bp12mo
A/R Days Reduction5200.0%3800.0%$275K+122bp9mo
Clean Claim Rate88.0%96.0%$14K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$475K
Cost to Collect
$452K
Denial Rate Reduction
$447K
A/R Days Reduction
$275K
Clean Claim Rate
$14K
Total EBITDA Uplift$1.7M
Current EBITDA$845K
+ RCM Uplift+$1.7M
Pro Forma EBITDA$2.5M
Current Margin3.7%
Pro Forma Margin11.1%
WC Released (1x)$867K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$1.3M$22.2M17.09x76.4%
Base (11x exit)10.0x11.0x$1.3M$24.8M19.12x80.4%
Bull Case9.0x11.0x$1.2M$30.8M26.30x92.3%
Bull (12x exit)9.0x12.0x$1.2M$33.9M28.99x96.1%
Bear Case11.0x10.0x$1.4M$13.5M9.42x56.6%
Bear (11x exit)11.0x11.0x$1.4M$15.3M10.69x60.6%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighElevated distress probabilityModel estimates 51.7% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 54 hospitals with 38-150 beds
  • Same-state prioritization (n=55)
  • Comp margins: P25=-10.9% / P50=2.2% / P75=10.2%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.